- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Daiichi Sankyo's total assets FY 2012-2017
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Daiichi Sankyo's total assets FY 2012-2017
Total assets of Daiichi Sankyo Co., Ltd. in fiscal years 2012 to 2017 (in trillion Japanese yen)
by Statista Research Department,
last edited
May 8, 2019
The statistic depicts the total assets of Daiichi Sankyo Co., Ltd. from fiscal year 2012 to 2017. In fiscal year 2017, the Japanese pharmaceutical company Daiichi Sankyo's total assets amounted to approximately 1.9 billion Japanese yen, up from around 1.68 trillion yen in fiscal year 2012.
Total assets of Daiichi Sankyo Co., Ltd. in fiscal years 2012 to 2017 (in trillion Japanese yen)
| Total assets in trillion Japanese yen | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Total assets in trillion Japanese yen | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Statista Research Department,
last edited
May 8, 2019
The statistic depicts the total assets of Daiichi Sankyo Co., Ltd. from fiscal year 2012 to 2017. In fiscal year 2017, the Japanese pharmaceutical company Daiichi Sankyo's total assets amounted to approximately 1.9 billion Japanese yen, up from around 1.68 trillion yen in fiscal year 2012.
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- December 2018
- Region
- Japan
- Survey time period
- fiscal years 2012 to 2017; the company’s fiscal year starts on April 1 of the stated year and ends on March 31 of the following year
- Supplementary notes
-
Figures are based on International Financial Reporting Standards (IFRS).
1 Japanese yen equals 0.009 U.S. dollars or 0.0081 euros as of May 2019.
Values have been rounded.
Source
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- December 2018
More information
- Region
- Japan
- Survey time period
- fiscal years 2012 to 2017; the company’s fiscal year starts on April 1 of the stated year and ends on March 31 of the following year
- Supplementary notes
-
Figures are based on International Financial Reporting Standards (IFRS).
1 Japanese yen equals 0.009 U.S. dollars or 0.0081 euros as of May 2019.
Values have been rounded.
Other statistics on the topic
+Pharmaceutical Products & Market
Research and development in European pharmaceutical industry by country 2017
+Pharmaceutical Products & Market
VAT rate on prescription-only drugs in Europe 2018
Pharmaceutical Products & Market
Market share of generics in European countries 2017
+Pharmaceutical Products & Market
Yearly growth rate of R&D spending in pharmaceutical industry 2004-2018
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Pharmaceutical trends in Europe"
- Overview
The most important statistics
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)Turnover of leading European pharmaceutical markets 2017
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)Turnover of pharmaceutical markets in Central and Eastern Europe 2017
- Share of breakdown of pharmaceutical price structure in Europe in 2016*Pharmaceutical price structure breakdown in Europe 2016
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*VAT rate on over-the-counter drugs in Europe 2018, by country
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by countryVAT rate on prescription-only drugs in Europe 2018
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*European Union: share of GDP expenditure on research and development 2000-2017
- Pharmaceutical research and development spending in selected European countries in 2017 (in million euros)Research and development in European pharmaceutical industry by country 2017
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2004 and 2018Yearly growth rate of R&D spending in pharmaceutical industry 2004-2018
- European Pharmaceutical companies
The most important statistics
- Leading 18 European pharmaceutical companies by retail sales in 2018 (in billion U.S. dollars)Leading 18 European pharmaceutical companies by retail sales 2018
- Leading European pharmaceutical companies by spending on research and development in 2018 (in billion U.S. dollars)Leading European pharmaceutical companies by R&D spending 2018
- Pharmaceutical production value of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical production value 1990-2018
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical R&D spending 1990-2018
- Self-medication market
The most important statistics
- Sales in the self-medication market in selected European countries in 2017 (in million euro)Self-medication market sales in Europe in 2017, by country
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)Self-medication market sales of analgesics in Europe in 2017, by country
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)Cough and cold self-medication market sales in Europe in 2017
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)Digestives and intestinal remedies self-medication market sales in Europe 2017
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)Self-medication skin treatment product sales in Europe 2017, by country
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)Self-medication: sales of vitamins and minerals in Europe 2017
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)Italy: market value of self-medication drugs 2014-2017
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)Sales revenue of self-care medicines in the Netherlands 2017, by purchase channel
- Employment
The most important statistics
- Pharmaceutical employment in selected European countries in 2017Employment in European pharmaceutical industry by country 2017
- Total pharmaceutical employment in EFPIA countries from 1990 to 2018Employment in EFPIA pharmaceutical industry 1990-2018
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)Pharmaceutical manufacturing employment in the United Kingdom 2008-2017
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017Switzerland: number of employees in biotech companies 2012-2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016Pharmaceutical industry: number of employees in Germany 2010-2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017Number of employees in the pharmaceutical industry in Belgium 2014-2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residenceNumber of employees of pharmaceutical companies by region France 2014
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2018Number of employees in the pharmaceutical industry in Italy 2000-2018
- Clinical Trials
The most important statistics
- Distribution of European clinical and phase III pipeline in 2013, by indicationDistribution of European clinical and phase III pipeline 2013 by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011Pivotal trials submitted to the European Medicines Agency from Europe 2005-2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011Patients in clinical trials in selected European countries 2005-2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017Clinical trial conduct applications in Germany 2009-2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017Italy: number of clinical trials authorized in Italy 2003-2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Daiichi Sankyo's total employees FY 2012-2017
- Daiichi Sankyo's female employee rate Japan FY 2014-2017
- Daiichi Sankyo's female employee rate consolidated FY 2015-2017
- Daiichi Sankyo's net income FY 2012-2017
- Daiichi Sankyo's R&D expenditure FY 2012-2017
- Otsuka Pharmaceutical's total assets 2009-2018
- Otsuka Pharmaceutical's R&D ratio 2009-2017
- Otsuka Pharmaceutical's female managers ratio 2014-2017
- Otsuka Pharmaceutical's operating income 2009-2018
- Otsuka Pharmaceutical's female managers 2014-2017
- Otsuka Pharmaceutical's total employees 2008-2017, by location
- Otsuka Pharmaceutical's R&D spending 2009-2018
- Otsuka Pharmaceutical's total employees 2009-2018
- Otsuka Pharmaceutical's net sales breakdown 2018, by segment
- Otsuka Pharmaceutical's net income 2009-2018
- Terumo R&D expenditure FY 2012-2017
- Revenue of LBF worldwide 2013-2015
- Production value of pharmaceuticals in Germany 2001-2017
- Export value of pharmaceuticals from Germany 2002-2017
- Gross profit of Sinopharm 2008-2018
Studies
- Biotechnology Industry in Europe
- Biotechnology in Germany
- Pharmaceutical industry in Italy
- Pharmaceutical trends in Europe
- Novo Nordisk ANNUAL REPORT 2017
- LEO Pharma A/S Annual Report 2017
- Lundbeck Annual Report 2017
- Sobi Anual and sustainability report 2017
- Pharmaceutical industry in the Netherlands
- Teva - 2018 Form 10-K
- Value and Innovation Framework Report 2019
- Dechra Pharmaceuticals PLC Annual Report 2018
- Indicatori Farmaceutici
- 2019 PhRMA Annual Membership Survey
- Medtronic - 2019 Form 10-K
Statistics on "Pharmaceutical trends in Europe"
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)
- Share of breakdown of pharmaceutical price structure in Europe in 2016*
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by country
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*
- Pharmaceutical research and development spending in selected European countries in 2017 (in million euros)
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2004 and 2018
- Market share of generics in selected European countries as of 2017
- Leading 18 European pharmaceutical companies by retail sales in 2018 (in billion U.S. dollars)
- Leading European pharmaceutical companies by spending on research and development in 2018 (in billion U.S. dollars)
- Pharmaceutical production value of EFPIA members from 1990 to 2018 (in million euros)
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2018 (in million euros)
- Sales in the self-medication market in selected European countries in 2017 (in million euro)
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)
- Sales revenue of self-care medicines in supermarkets in the Netherlands in 2017, by product segment (in million euros)
- Pharmaceutical employment in selected European countries in 2017
- Total pharmaceutical employment in EFPIA countries from 1990 to 2018
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residence
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2018
- Distribution of European clinical and phase III pipeline in 2013, by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017
- Number of employees working for Daiichi Sankyo Co., Ltd. in fiscal years 2012 to 2017 (in 1,000s)
- Rate of female employees working for Daiichi Sankyo Co., Ltd. in Japan in fiscal years 2014 to 2017
- Rate of female employees working for Daiichi Sankyo Co., Ltd. and its subsidiaries in Japan and overseas in fiscal years 2015 to 2017
- Annual profit of Daiichi Sankyo Co., Ltd. in fiscal years 2012 to 2017 (in billion Japanese yen)*
- Annual research and development expenses of Daiichi Sankyo Co., Ltd. in fiscal years 2012 to 2017 (in billion Japanese yen)
- Total assets of Otsuka Pharmaceutical Co., Ltd. in fiscal years 2009 to 2018 (in trillion Japanese yen)
- Research and development (R&D) ratio of Otsuka Pharmaceutical Co., Ltd. in fiscal years 2009 to 2017
- Ratio of female employees working in managerial positions for Otsuka Pharmaceutical Co., Ltd. in fiscal years 2014 to 2017
- Operating profit of Otsuka Pharmaceutical Co., Ltd. from fiscal year 2009 to 2018 (in billion Japanese yen)
- Number of female employees working in managerial positions for Otsuka Pharmaceutical Co., Ltd. in fiscal years 2014 to 2017
- Number of employees working for Otsuka Pharmaceutical Co., Ltd. in fiscal years 2008 to 2017, by location (in 1,000s)*
- Research and development expenses of Otsuka Pharmaceutical Co., Ltd. in fiscal years 2009 to 2018 (in billion Japanese yen)
- Number of employees working for Otsuka Pharmaceutical Co., Ltd. in fiscal years 2009 to 2018 (in 1,000s)*
- Net sales distribution of Otsuka Pharmaceutical Co., Ltd. in fiscal year 2018, by business segment*
- Annual profit of Otsuka Pharmaceutical Co., Ltd. from fiscal year 2009 to 2018 (in billion Japanese yen)*
- Research and Development (R&D) expenses of Terumo Corporation in fiscal years 2012 to 2017 (in billion Japanese yen)*
- Revenue of the French Fractioning and Biotechnologies Laboratory (LBF) worldwide from 2013 to 2015 (in million euros)
- Value of pharmaceutical production in Germany from 2001 to 2017* (in billion euros)
- Value of pharmaceutical drugs exported from Germany from 2002 to 2017* (in million euros)
- Gross profit of Sinopharm from 2008 to 2018 (in billion yuan)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.